Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 17 Issue 1, January 2022

Nanotubes bridge cancer and immune cells

The image is an artistic representation depicting cancer cells physically connecting to T cells through nanotubes. Cancer cells harvest mitochondria from T cells. Inhibiting this mechanism can augment the immune response against cancer cells.

See Sengupta

IMAGE: Ella Marushenko and Kate Zvorykina (Ella Maru Studio) COVER DESIGN: Lauren Heslop.

News & Views

  • Supramolecular arrangement of proteins provides nanoparticles with neutrophil tropism via complement opsonization during an acute inflammation, enabling diagnosis and treatment of acute lung injury.

    • Jeonghwan Kim
    • Gaurav Sahay
    News & Views

    Advertisement

  • Nanotube-mediated acquisition of immune cells’ mitochondria by tumour cells is a novel mechanism for immune evasion that can be pharmacologically targeted to potentiate cancer immunotherapies.

    • Jeremy G. Baldwin
    • Luca Gattinoni
    News & Views
Top of page ⤴

Review Articles

  • This Review discusses the progresses in label-free nanophotonic biosensors based on photonic or dielectric surfaces and metasurfaces and highlights the challenges and benefits of their applications in the fields of public health, well-being and biosafety.

    • Hatice Altug
    • Sang-Hyun Oh
    • Jiří Homola
    Review Article
Top of page ⤴

Matters Arising

Top of page ⤴

Letters

Top of page ⤴

Articles

Top of page ⤴

Search

Quick links